810857P
Avanti
14:0 NPS PC
1-myristoyl-2-(4-nitrophenylsuccinyl)-sn-glycero-3-phosphocholine, powder
Synonym(s):
1-tetradecanoyl-2-(4-nitrophenylsuccinyl)-sn-glycero-3-phosphocholine
Sign Into View Organizational & Contract Pricing
All Photos(2)
About This Item
Empirical Formula (Hill Notation):
C32H53N2O12P
CAS Number:
Molecular Weight:
688.74
UNSPSC Code:
12352211
NACRES:
NA.25
Recommended Products
Assay
>99% (TLC)
form
powder
packaging
pkg of 1 × 100 mg (810857P-100mg)
pkg of 2 × 100 mg (810857P-200mg)
pkg of 1 × 25 mg (810857P-25mg)
manufacturer/tradename
Avanti Research™ - A Croda Brand 810857P
shipped in
dry ice
storage temp.
−20°C
Packaging
5 mL Clear Glass Sealed Ampule (810857P-100mg)
5 mL Clear Glass Sealed Ampule (810857P-200mg)
5 mL Clear Glass Sealed Ampule (810857P-25mg)
Legal Information
Avanti Research is a trademark of Avanti Polar Lipids, LLC
Storage Class Code
11 - Combustible Solids
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
T Kosaka et al.
Clinica chimica acta; international journal of clinical chemistry, 312(1-2), 179-183 (2001-10-03)
A spectrophotometric assay for platelet-activating factor acetylhydrolase (PAF-AH) activity differs from the radioisotopic assay in its value because of a difference in substrate specificity. The spectrophotometric assay is more precise than the radioisotopic assay, providing information that is not clear
Karl Winkler et al.
Circulation, 111(8), 980-987 (2005-02-16)
Platelet-activating factor acetylhydrolase (PAF-AH), also denoted as lipoprotein-associated phospholipase A2, is a lipoprotein-bound enzyme that is possibly involved in inflammation and atherosclerosis. This study investigates the relationship of PAF-AH activity to angiographic coronary artery disease (CAD), the use of cardiovascular
T Kosaka et al.
Clinica chimica acta; international journal of clinical chemistry, 296(1-2), 151-161 (2000-05-16)
We developed a spectrophotometric assay for serum platelet-activating factor acetylhydrolase (PAF-AH, EC 3.1.1.47.) activity using a platelet-activating factor (PAF) analogue with a 4-nitrophenyl group as substrate. PAF-AH hydrolyzes the sn-2 position of the substrate ¿1-myristoyl-2-(p-nitrophenylsuccinyl)phosphatidylcholine, producing p-nitrophenyl succinate. This liberation
M Serban et al.
Journal of cellular and molecular medicine, 6(4), 643-647 (2003-03-04)
Non-insulin dependent diabetes mellitus (NIDDM) represents an independent risk factor for cardiovascular diseases (CVD), being characterized by a continuous low-grade inflammation and endothelial activation state. Plasma platelet - activating factor - acetylhydrolases (PAF-AHs) are a subgroup of Ca(2+)-independent phospholipase A(2)
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service